Bio-Rad Laboratories (NYSE:BIO) was downgraded by analysts at
Weiss Ratings from a "hold (c-)" rating to a "sell (d-)" rating.
Bio-Rad Laboratories (NYSE:BIO) was upgraded by analysts at
Wall Street Z
Bio-Rad Laboratories (NYSE:BIO) had its price target raised by analysts at Citigroup Inc. from $350.00 to $375.00. They now have a "buy" rating on the stock.
Bio-Rad Laboratories (NYSE:BIO) was upgraded by analysts at
Weiss Ratings from a "sell (d+)" rating to a "hold (c-)" rating.
Bio-Rad Laboratories (NYSE:BIO) had its price target raised by analysts at Wells Fargo & Company from $265.00 to $340.00. They now have an "equal weight" rating on the stock.